{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T03:36:31Z","timestamp":1788233791858,"version":"build-2803163510"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,31]],"date-time":"2027-01-31T00:00:00Z","timestamp":1801353600000},"content-version":"am","delay-in-days":336,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100018432","name":"California NanoSystems Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018432","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["HL151391"],"award-info":[{"award-number":["HL151391"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["HL137647"],"award-info":[{"award-number":["HL137647"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.atherosclerosis.2026.120649","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T16:58:39Z","timestamp":1769533119000},"page":"120649","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Specific serotonin receptor antagonist reduces murine calcific atherosclerosis"],"prefix":"10.1016","volume":"414","author":[{"given":"Andy","family":"Hon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mimi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda L.","family":"Demer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0156-2307","authenticated-orcid":false,"given":"Yin","family":"Tintut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120649_bib1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2143\/AC.57.1.2005372","article-title":"Coronary artery calcification and dietary cholesterol intake in Korean men","volume":"57","author":"Oh","year":"2002","journal-title":"Acta Cardiol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120649_bib2","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.atherosclerosis.2008.03.014","article-title":"Non-HDL cholesterol is strongly associated with coronary artery calcification in asymptomatic individuals","volume":"202","author":"Orakzai","year":"2009","journal-title":"Atherosclerosis"},{"issue":"2\u20133","key":"10.1016\/j.atherosclerosis.2026.120649_bib3","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0021-9150(91)90020-4","article-title":"Calcification of aortic wall in cholesterol-fed rabbits","volume":"87","author":"Rokita","year":"1991","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120649_bib4","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1186\/s12891-021-04643-5","article-title":"Association between lipid biomarkers and osteoporosis: a cross-sectional study","volume":"22","author":"Kan","year":"2021","journal-title":"BMC Muscoskelet Disord"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.120649_bib5","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.bone.2008.09.020","article-title":"Association between serum cholesterol and bone mineral density","volume":"44","author":"Makovey","year":"2009","journal-title":"Bone"},{"issue":"41","key":"10.1016\/j.atherosclerosis.2026.120649_bib6","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1093\/eurheartj\/ehy534","article-title":"Sex differences in calcified plaque and long-term cardiovascular mortality: observations from the CAC consortium","volume":"39","author":"Shaw","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.atherosclerosis.2026.120649_bib7","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.16546","article-title":"Association between osteoporosis and cardiovascular disease in elderly people: evidence from a retrospective study","volume":"11","author":"Hu","year":"2023","journal-title":"PeerJ"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.120649_bib8","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.clim.2009.07.011","article-title":"Oxidized lipids enhance RANKL production by T lymphocytes: implications for lipid-induced bone loss","volume":"133","author":"Graham","year":"2009","journal-title":"Clin Immunol"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2026.120649_bib9","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1359\/jbmr.080513","article-title":"Hyperlipidemia impairs osteoanabolic effects of PTH","volume":"23","author":"Huang","year":"2008","journal-title":"J Bone Miner Res"},{"issue":"29","key":"10.1016\/j.atherosclerosis.2026.120649_bib10","doi-asserted-by":"crossref","first-page":"21237","DOI":"10.1074\/jbc.M701341200","article-title":"Atherogenic phospholipids attenuate osteogenic signaling by BMP-2 and parathyroid hormone in osteoblasts","volume":"282","author":"Huang","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2026.120649_bib11","article-title":"The effects of hyperlipidemia on implant osseointegration in the mouse femur","author":"Keuroghlian","year":"2013","journal-title":"J Oral Implantol"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2026.120649_bib12","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1359\/jbmr.1999.14.12.2067","article-title":"Atherogenic diet and minimally oxidized low density lipoprotein inhibit osteogenic and promote adipogenic differentiation of marrow stromal cells","volume":"14","author":"Parhami","year":"1999","journal-title":"J Bone Miner Res"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.120649_bib13","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1161\/01.ATV.17.4.680","article-title":"Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients","volume":"17","author":"Parhami","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120649_bib14","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1359\/jbmr.2001.16.1.182","article-title":"Atherogenic high-fat diet reduces bone mineralization in mice","volume":"16","author":"Parhami","year":"2001","journal-title":"J Bone Miner Res"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.120649_bib15","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/jbmr.541","article-title":"Adverse effects of hyperlipidemia on bone regeneration and strength","volume":"27","author":"Pirih","year":"2012","journal-title":"J Bone Miner Res"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.120649_bib16","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1002\/jbmr.312","article-title":"Hyperlipidemia induces resistance to PTH bone anabolism in mice via oxidized lipids","volume":"26","author":"Sage","year":"2011","journal-title":"J Bone Miner Res"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.120649_bib17","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1161\/01.ATV.0000112023.62695.7f","article-title":"Hyperlipidemia promotes osteoclastic potential of bone marrow cells ex vivo","volume":"24","author":"Tintut","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5603","key":"10.1016\/j.atherosclerosis.2026.120649_bib18","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1126\/science.1078197","article-title":"Synthesis of serotonin by a second tryptophan hydroxylase isoform","volume":"299","author":"Walther","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.atherosclerosis.2026.120649_bib19","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1146\/annurev.med.60.042307.110802","article-title":"The expanded biology of serotonin","volume":"60","author":"Berger","year":"2009","journal-title":"Annu Rev Med"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120649_bib20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/ajh.23855","article-title":"Platelet activation and arterial peripheral serotonin turnover in cardiac remodeling associated to aortic stenosis","volume":"90","author":"Rouzaud-Laborde","year":"2015","journal-title":"Am J Hematol"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2026.120649_bib21","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1084\/jem.20012044","article-title":"A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation","volume":"196","author":"Massberg","year":"2002","journal-title":"J Exp Med"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2026.120649_bib22","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1161\/01.CIR.100.5.483","article-title":"Serotonin is associated with coronary artery disease and cardiac events","volume":"100","author":"Vikenes","year":"1999","journal-title":"Circulation"},{"issue":"17","key":"10.1016\/j.atherosclerosis.2026.120649_bib23","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1093\/eurheartj\/ehy696","article-title":"Activated platelets promote an osteogenic programme and the progression of calcific aortic valve stenosis","volume":"40","author":"Bouchareb","year":"2019","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.120649_bib24","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/nm.2098","article-title":"Pharmacological inhibition of gut-derived serotonin synthesis is a potential bone anabolic treatment for osteoporosis","volume":"16","author":"Yadav","year":"2010","journal-title":"Nat Med"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2026.120649_bib25","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1001\/archinte.167.12.1240","article-title":"Use of antidepressants and rates of hip bone loss in older women: the study of osteoporotic fractures","volume":"167","author":"Diem","year":"2007","journal-title":"Arch Intern Med"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.120649_bib26","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1097\/gme.0b013e318173566b","article-title":"Serotonin (5-hydroxytryptamine) transporter inhibition causes bone loss in adult mice independently of estrogen deficiency","volume":"15","author":"Warden","year":"2008","journal-title":"Menopause"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2026.120649_bib27","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1002\/jbmr.439","article-title":"Efficacy of serotonin inhibition in mouse models of bone loss","volume":"26","author":"Inose","year":"2011","journal-title":"J Bone Miner Res"},{"issue":"22","key":"10.1016\/j.atherosclerosis.2026.120649_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/nu14224718","article-title":"The lignan-rich fraction from Sambucus williamsii hance exerts bone protective effects via altering circulating serotonin and gut microbiota in rats","volume":"14","author":"Xiao","year":"2022","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.120649_bib29","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/jcb.29847","article-title":"Serotonin receptor type 2B activation augments TNF-alpha-induced matrix mineralization in murine valvular interstitial cells","volume":"122","author":"Fong","year":"2021","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.atherosclerosis.2026.120649_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2024.149854","article-title":"Effects of LP533401 on vascular and bone calcification in hyperlipidemic mice","volume":"710","author":"Pradhan","year":"2024","journal-title":"Biochem Biophys Res Commun"},{"issue":"2 Pt 1","key":"10.1016\/j.atherosclerosis.2026.120649_bib31","doi-asserted-by":"crossref","first-page":"C309","DOI":"10.1152\/ajpcell.1992.262.2.C309","article-title":"5-HT2 receptor mRNA is overexpressed in cultured rat aortic smooth muscle cells relative to normal aorta","volume":"262","author":"Corson","year":"1992","journal-title":"Am J Physiol"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.120649_bib32","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0014-5793(95)00828-W","article-title":"Expression of serotonin receptor mRNAs in blood vessels","volume":"370","author":"Ullmer","year":"1995","journal-title":"FEBS Lett"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2026.120649_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0238407","article-title":"Genetic ablation of serotonin receptor 2B improves aortic valve hemodynamics of Notch1 heterozygous mice in a high-cholesterol diet model","volume":"15","author":"Joll","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.atherosclerosis.2026.120649_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.vph.2024.107376","article-title":"Effects of empagliflozin on vascular and skeletal mineralization in hyperlipidemic mice","author":"Kalanski","year":"2024","journal-title":"Vasc Pharmacol"},{"key":"10.1016\/j.atherosclerosis.2026.120649_bib35","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.yjmcc.2017.12.014","article-title":"Serotonin receptor 2B signaling with interstitial cell activation and leaflet remodeling in degenerative mitral regurgitation","volume":"115","author":"Driesbaugh","year":"2018","journal-title":"J Mol Cell Cardiol"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.120649_bib36","first-page":"H944","article-title":"5-HT2B-receptor antagonist LY-272015 is antihypertensive in DOCA-salt-hypertensive rats","volume":"276","author":"Watts","year":"1999","journal-title":"Am J Physiol"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.120649_bib37","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1162\/153535003322556877","article-title":"AMIDE: a free software tool for multimodality medical image analysis","volume":"2","author":"Loening","year":"2003","journal-title":"Mol Imaging"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.120649_bib38","doi-asserted-by":"crossref","first-page":"H1203","DOI":"10.1152\/ajpheart.00718.2017","article-title":"Effects of teriparatide on morphology of aortic calcification in aged hyperlipidemic mice","volume":"314","author":"Hsu","year":"2018","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.120649_bib39","doi-asserted-by":"crossref","first-page":"e185","DOI":"10.1161\/ATVBAHA.120.315737","article-title":"Statin effects on vascular calcification: microarchitectural changes in aortic calcium deposits in aged hyperlipidemic mice","volume":"41","author":"Xian","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2026.120649_bib40","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1002\/jcb.25186","article-title":"Protective role of Smad6 in inflammation-induced valvular cell calcification","volume":"116","author":"Li","year":"2015","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.atherosclerosis.2026.120649_bib41","doi-asserted-by":"crossref","first-page":"553","DOI":"10.3389\/fphar.2020.00553","article-title":"Gut-derived serotonin contributes to the progression of non-alcoholic steatohepatitis via the liver HTR2A\/PPARgamma2 pathway","volume":"11","author":"Wang","year":"2020","journal-title":"Front Pharmacol"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2026.120649_bib42","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1161\/01.ATV.19.5.1333","article-title":"CD36, a novel receptor for oxidized low-density lipoproteins, is highly expressed on lipid-laden macrophages in human atherosclerotic aorta","volume":"19","author":"Nakata","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2026.120649_bib43","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.bbrc.2021.11.103","article-title":"Genome-wide survey and functional analysis reveal TCF21 promotes chicken preadipocyte differentiation by directly upregulating HTR2A","volume":"587","author":"Zhang","year":"2022","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.120649_bib44","doi-asserted-by":"crossref","first-page":"322","DOI":"10.5551\/jat.58305","article-title":"5-HT(2A) receptor and 5-HT degradation play a crucial role in atherosclerosis by modulating macrophage foam cell formation, vascular endothelial cell inflammation, and hepatic steatosis","volume":"29","author":"Ma","year":"2022","journal-title":"J Atherosclerosis Thromb"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2026.120649_bib45","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1139\/Y10-079","article-title":"Effects of low-dose ketanserin on atherosclerosis in rats and rabbits","volume":"88","author":"Yu","year":"2010","journal-title":"Can J Physiol Pharmacol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120649_bib46","doi-asserted-by":"crossref","first-page":"64","DOI":"10.7150\/ijbs.7894","article-title":"A xanthine-derivative K(+)-channel opener protects against serotonin-induced cardiomyocyte hypertrophy via the modulation of protein kinases","volume":"10","author":"Kuo","year":"2013","journal-title":"Int J Biol Sci"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.120649_bib47","doi-asserted-by":"crossref","first-page":"H821","DOI":"10.1152\/ajpheart.00345.2009","article-title":"Dose-dependent activation of distinct hypertrophic pathways by serotonin in cardiac cells","volume":"297","author":"Villeneuve","year":"2009","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.120649_bib48","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2478\/abm-2022-0010","article-title":"Serotonin receptor subtype-2B signaling is associated with interleukin-18-induced cardiomyoblast hypertrophy in vitro","volume":"16","author":"Chen","year":"2022","journal-title":"Asian Biomed"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2026.120649_bib49","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1161\/01.CIR.0000139856.20505.57","article-title":"Involvement of the serotonin 5-HT2B receptor in cardiac hypertrophy linked to sympathetic stimulation: control of interleukin-6, interleukin-1beta, and tumor necrosis factor-alpha cytokine production by ventricular fibroblasts","volume":"110","author":"Jaffre","year":"2004","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.120649_bib50","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s00702-013-1011-3","article-title":"Role of serotonin 5-HT2A receptors in the development of cardiac hypertrophy in response to aortic constriction in mice","volume":"120","author":"Lairez","year":"2013","journal-title":"J Neural Transm (Vienna)"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.120649_bib51","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.febslet.2011.12.015","article-title":"Phosphorylation of Akt\/GSK-3beta\/eNOS amplifies 5-HT2B receptor blockade mediated anti-hypertrophic effect in rats","volume":"586","author":"Bharti","year":"2012","journal-title":"FEBS Lett"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2026.120649_bib52","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1097\/HJH.0000000000000695","article-title":"Contribution of serotonin to cardiac remodeling associated with hypertensive diastolic ventricular dysfunction in rats","volume":"33","author":"Ayme-Dietrich","year":"2015","journal-title":"J Hypertens"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.120649_bib53","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/BF00054191","article-title":"Comparison of ketanserin and celiprolol on regression of left ventricular hypertrophy in older hypertensive patients","volume":"6","author":"Vyssoulis","year":"1992","journal-title":"Cardiovasc Drugs Ther"},{"issue":"Suppl 1","key":"10.1016\/j.atherosclerosis.2026.120649_bib54","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/BF00053433","article-title":"Left ventricular hypertrophy regression and function changes with ketanserin in elderly hypertensives","volume":"4","author":"Vyssoulis","year":"1990","journal-title":"Cardiovasc Drugs Ther"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.120649_bib55","doi-asserted-by":"crossref","first-page":"L542","DOI":"10.1152\/ajplung.00166.2015","article-title":"Genetic ablation of interleukin-18 does not attenuate hypobaric hypoxia-induced right ventricular hypertrophy","volume":"310","author":"Bruns","year":"2016","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"22","key":"10.1016\/j.atherosclerosis.2026.120649_bib56","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.022077","article-title":"Loss of endothelial hypoxia inducible factor-prolyl hydroxylase 2 induces cardiac hypertrophy and fibrosis","volume":"10","author":"Dai","year":"2021","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.120649_bib57","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.cardiores.2005.01.021","article-title":"Concentric left ventricular remodeling in endothelial nitric oxide synthase knockout mice by chronic pressure overload","volume":"66","author":"Ruetten","year":"2005","journal-title":"Cardiovasc Res"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.120649_bib58","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1365-2125.1983.tb02166.x","article-title":"The effect of a 5-HT antagonist, ketanserin, on blood pressure, the renin-angiotensin system and sympathoadrenal function in normal man","volume":"16","author":"Zoccali","year":"1983","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.120649_bib59","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1124\/pr.111.004697","article-title":"Serotonin and blood pressure regulation","volume":"64","author":"Watts","year":"2012","journal-title":"Pharmacol Rev"},{"issue":"31","key":"10.1016\/j.atherosclerosis.2026.120649_bib60","doi-asserted-by":"crossref","first-page":"28961","DOI":"10.1074\/jbc.M101824200","article-title":"Expression of serotonin receptors in bone","volume":"276","author":"Westbroek","year":"2001","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.120649_bib61","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1096\/fj.07-9209com","article-title":"The serotonin 5-HT2B receptor controls bone mass via osteoblast recruitment and proliferation","volume":"22","author":"Collet","year":"2008","journal-title":"FASEB J"},{"issue":"1\u20132","key":"10.1016\/j.atherosclerosis.2026.120649_bib62","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0304-3940(96)12307-7","article-title":"Sex difference in 5HT2 receptor in the living human brain","volume":"204","author":"Biver","year":"1996","journal-title":"Neurosci Lett"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2026.120649_bib63","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1161\/ATVBAHA.107.144675","article-title":"RhoA activation contributes to sex differences in vascular contractions","volume":"27","author":"Nuno","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.120649_bib64","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1161\/01.ATV.21.4.523","article-title":"Role of sex differences and effects of endothelial NO synthase deficiency in responses of carotid arteries to serotonin","volume":"21","author":"Lamping","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2026.120649_bib65","first-page":"218","article-title":"Ketanserin in chronic treatment of hypertension in type 2 diabetes mellitus","volume":"28","author":"Fogari","year":"1990","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"issue":"Suppl 1","key":"10.1016\/j.atherosclerosis.2026.120649_bib66","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/BF00053443","article-title":"Comparison of ketanserin and enalapril in the treatment of mild-to-moderate essential hypertension","volume":"4","author":"Malatino","year":"1990","journal-title":"Cardiovasc Drugs Ther"},{"issue":"Suppl 3","key":"10.1016\/j.atherosclerosis.2026.120649_bib67","first-page":"S119","article-title":"Antihypertensive efficacy of ketanserin alone or in combination with a beta-blocker or a diuretic: the Swiss ketanserin study","volume":"10","author":"Beretta-Piccoli","year":"1987","journal-title":"J Cardiovasc Pharmacol"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.120649_bib68","first-page":"103","article-title":"Antihypertensive and metabolic effects of ketanserin in diabetic patients with mild hypertension","volume":"2","author":"Beretta-Piccoli","year":"1988","journal-title":"J Hum Hypertens"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2026.120649_bib69","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1002\/j.1552-4604.1990.tb03482.x","article-title":"Effects of ketanserin on lipids, lipoproteins, and plasma atrial natriuretic factor in patients with essential hypertension","volume":"30","author":"Bielmann","year":"1990","journal-title":"J Clin Pharmacol"},{"issue":"Suppl 1","key":"10.1016\/j.atherosclerosis.2026.120649_bib70","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2165\/00003495-198800361-00006","article-title":"Effects of ketanserin tartrate on serum lipids in patients with essential hypertension","volume":"36","author":"Nakamura","year":"1988","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120649_bib71","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/clpt.1986.139","article-title":"Ketanserin and prazosin: a comparison of antihypertensive and biochemical effects","volume":"40","author":"Stokes","year":"1986","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.120649_bib72","first-page":"91","article-title":"Haemodynamic and metabolic effects of ketanserin in dyslipidaemic hypertensive subjects","volume":"13","author":"Letizia","year":"1991","journal-title":"Int J Tissue React"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2026.120649_bib73","first-page":"455","article-title":"Effects of ketanserin administration on lipid metabolism and platelet aggregation in hypertensive patients","volume":"28","author":"Loschiavo","year":"1990","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120649_bib74","first-page":"S99","article-title":"Regional haemodynamics and antihypertensive effects during long-term ketanserin treatment","volume":"4","author":"Persson","year":"1986","journal-title":"J Hypertens"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.120649_bib75","first-page":"95","article-title":"[influence of chronic ketanserin therapy on blood pressure and certain humoral and metabolic factors in patients with mild to moderate primary essential hypertension]","volume":"90","author":"Knypl","year":"1993","journal-title":"Pol Arch Med Wewn"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.120649_bib76","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1097\/00005344-198712000-00007","article-title":"Serum cholesterol during ketanserin and propranolol administration in hypertensive patients","volume":"10","author":"Lijnen","year":"1987","journal-title":"J Cardiovasc Pharmacol"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.120649_bib77","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1001\/archinte.1987.00370020109046","article-title":"Comparison of ketanserin and metoprolol in the treatment of essential hypertension","volume":"147","author":"Sheps","year":"1987","journal-title":"Arch Intern Med"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.120649_bib78","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1161\/01.HYP.8.2.167","article-title":"Chronic effect of ketanserin in mild to moderate essential hypertension","volume":"8","author":"Woittiez","year":"1986","journal-title":"Hypertension"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915026000158?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915026000158?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T11:05:38Z","timestamp":1783595138000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915026000158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":78,"alternative-id":["S0021915026000158"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2026.120649","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Specific serotonin receptor antagonist reduces murine calcific atherosclerosis","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2026.120649","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"120649"}}